Development of Monoclonal Antibodies against CMP-N-Acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3Gal-I) Recombinant Protein Expressed in<i> E. coli</i>

<div>Silver stained SDS-PAGE analysis of purified recombinant rST3Gal-I. Lane 1: protein Molecular weight marker from Merck; lanes 2 and 3: purified recombinant ST3Gal-I protein (2 <i>μ</i>g and 1 <i>μ</i>g, resp.).</div>

Biochemistry Research International

fig3

Figure 3

Figure 3: Development of Monoclonal Antibodies against CMP-N-Acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3Gal-I) Recombinant Protein Expressed in<i> E. coli</i> 

Figure 3 | Development of Monoclonal Antibodies against CMP-N-Acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3Gal-I) Recombinant Protein Expressed in E. coli 